Antibody drug tech firm AbCellera raises $105 million as it works on COVID-19
Canadian drug discovery technology company AbCellera, which analyzes and identifies antibodies for pharmaceutical companies working on a coronavirus treatment and other medicines, said on Wednesday it had raised $105 million in funds.
